Clinical prognostic value of TREM1 in patients with liver cancer lung metastasis
Increased expression of TREM1 in HCC is linked to a poorer clinical outlook and elevated incidence of lung metastasis, suggesting its potential as a prognostic biomarker for patients with liver cancer lung metastasis.
Authors
- Yanze Yin
- Qiang Xia (ORCID: https://orcid.org/0000-0001-9482-6951)
- Jie Cai (ORCID: https://orcid.org/0000-0002-2691-0411)
- Y. Luo (ORCID: https://orcid.org/0009-0009-5091-164X)
Institutions
- Tongji University (CN)
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
- Shanghai Pulmonary Hospital (CN)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tcr-24-492
- Primary Topic
- Inflammation biomarkers and pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanghai
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Renji Hospital